Fundraising Fox
Ubique Bio
3 known investors
Find your way into Ubique Bio
Sign up to see every warm intro you have to Ubique Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ubique Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
Investors · 3
Extreme Venture PartnersreportedToronto · $182.5K – $1.1M
How we know: funding news · Not right? Tell us
InnovacorpreportedHalifax
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Ubique Bio do?
- Ubique Biotech develops AI-designed synthetic reagents (antigen and antibody based) for precision diagnostics used in formats such as ELISA and rapid point-of-care tests. Founded in 2022, it focuses on affordable, scalable disease detection and screening without extensive laboratory infrastructure.
- Who are Ubique Bio's investors?
- Ubique Bio's investors include GRIDX, Extreme Venture Partners, Innovacorp.